5月5日 - ** 生物科技公司Ocugen（OCGN.O）股价暴跌19%，至1.50美元
** 宣布通过私募向机构投资者发行2034年到期的可转换债券，发行规模为1.15亿美元（(link)）
** 所得款项将用于偿还债务及其他用途
** 此外，OCGN报告称 (link) 第一季度净亏损1920万美元，而去年同期净亏损为1540万美元
** 据伦敦证券交易所集团（LSEG）数据显示，OCGN目前流通股为3.385亿股
** 覆盖该股的七家券商均给予“买入”或更高评级；目标价中位数为10美元——数据由LSEG汇编
** 截至上一交易日收盘，OCGN股价年内累计上涨37%
(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.